Quick answer: The ZYN modified risk claim can now be used for 20 specific ZYN nicotine pouch products after FDA issued modified risk granted orders on June 30, 2026. The order is product-specific, expires in five years unless renewed, and does not turn every nicotine pouch or ZYN marketing claim into an FDA-authorized claim.
| Field | Detail |
|---|---|
| Source status | FDA CTP newsroom and FDA ZYN MRTP application page |
| Date | June 30, 2026 |
| Jurisdiction | United States |
| Affected entities | Swedish Match USA, Inc.; 20 ZYN nicotine pouch products |
| Buyer / retailer relevance | Claim language is product-specific and tied to FDA modified risk granted orders, postmarket surveillance, and expiration timing |
What happened?
The U.S. Food and Drug Administration issued modified risk granted orders to Swedish Match USA, Inc. for 20 ZYN nicotine pouch products. FDA says those products were already authorized for U.S. sale through the premarket tobacco product application pathway in January 2025, and the new order allows a specific modified risk marketing claim for the covered products.
The order covers ten ZYN varieties, each in 3mg and 6mg strengths: Chill, Cinnamon, Citrus, Coffee, Cool Mint, Menthol, Peppermint, Smooth, Spearmint, and Wintergreen.
ZYN pouches are oral nicotine products rather than e-liquid or ENDS products. For formulation and label context relevant to e-liquids, see Nicotine Salt vs Freebase Nicotine; it does not determine the scope of this pouch order.
What does the ZYN modified risk claim order allow?
The ZYN modified risk claim order allows Swedish Match to market the covered products with the specific claim authorized by FDA. It does not authorize every nicotine pouch brand, every ZYN product, or broader unreviewed wording.
For buyers and retailers, the important detail is that modified risk tobacco product status is attached to named products and specific claim language. That makes SKU matching, claim matching, and supplier documentation part of the compliance check.
Why does it matter for claim verification?
The June 30 order is useful because it separates three ideas that are often blurred in nicotine marketing:
- FDA market authorization means a product may be legally marketed after FDA review.
- FDA modified risk authorization means a specific product may use a specific reduced-risk or reduced-exposure claim.
- Ordinary brand marketing copy still needs evidence and cannot be treated as FDA-cleared just because the brand has one authorized product or claim.
That same distinction also matters in VapeRisk’s FDA-authorized e-cigarettes and ENDS guide. Those marketing authorizations concern e-cigarettes/ENDS; the ZYN order concerns named oral nicotine pouch products and separate modified-risk claim language.
VapeRisk risk read
The main channel risk is overextension. A retailer, affiliate page, distributor catalog, or paid ad could turn a narrow FDA order into a broader message that all nicotine pouches, all ZYN products, or all pouch-related claims are FDA-authorized. That would be a weak compliance position.
The safer documentation approach is to keep a copy of the FDA order source, match the exact product and strength, preserve the approved claim wording, and avoid adding extra health, cessation, or safety language around it.
What remains unverified?
FDA’s public release explains the order, product list, surveillance requirement, and five-year expiration. It does not answer how every retailer, marketplace, affiliate, or state regulator will police downstream claim language. It also does not make the selected ZYN products risk-free, and VapeRisk is not treating the order as a recommendation to use nicotine products.
Buyer and retailer watch list
- Confirm whether the product, flavor, and nicotine strength are inside the 20-product FDA order.
- Keep the FDA source URL or order letter with supplier files.
- Do not convert the authorized claim into a broader category claim.
- Do not imply FDA authorized a cessation claim.
- Recheck the order status before relying on it after the five-year window.
FAQ
Does the ZYN modified risk claim apply to every nicotine pouch?
No. The ZYN modified risk claim applies to the specific ZYN products covered by FDA’s June 30, 2026 modified risk granted orders. It should not be applied to other nicotine pouch brands or unlisted products.
Is a modified risk order the same as basic FDA market authorization?
No. FDA market authorization lets a specific product be legally marketed after review. A modified risk order is a separate authorization for a specific risk-related marketing claim.
Does the FDA ZYN order mean the products are risk-free?
No. FDA’s own release says there is no safe tobacco product. VapeRisk reads the order as a product-specific marketing-claim authorization, not as a safety guarantee or a recommendation.
Related VapeRisk Coverage
- Vape Compliance Market
- FDA Nicotine Pouch Environmental Assessment Shows PMTA Review Is Wider Than Labels
- PMTA Is Not an FDA Approved Badge